Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 May;88(5):431-432.
doi: 10.1007/s12098-021-03732-6. Epub 2021 Mar 26.

Vasopressin in Persistent Pulmonary Hypertension of Newborn

Deepak Chawla  1
Affiliations
Editorial

Vasopressin in Persistent Pulmonary Hypertension of Newborn

Deepak Chawla. Indian J Pediatr. 2021 May.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Lai M-Y, Chu S-M, Lakshminrusimha S, Lin H-C. Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Pediatr Neonatol. 2018;59:15–23. - DOI
    1. Jain A, McNamara PJ. Persistent pulmonary hypertension of the newborn: advances in diagnosis and treatment. Semin Fetal Neonatal Med. 2015;20:262–71. - DOI
    1. Nakwan N, Jain S, Kumar K, et al. An Asian multicenter retrospective study on persistent pulmonary hypertension of the newborn: incidence, etiology, diagnosis, treatment and outcome. J Matern Fetal Neonatal Med. 2020;33:2032–7. - DOI
    1. Tayama E, Ueda T, Shojima T, et al. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovasc Thorac Surg. 2007;6:715–9. - DOI
    1. Khare C, Adhisivam B, Bhat BV, Vaishnav D. Utility of low dose vasopressin for persistent pulmonary hypertension of newborn with catecholamine refractory shock. Indian J Pediatr. 2020 Oct 8. https://doi.org/10.1007/s12098-020-03519-1 . Accessed 21 Feb 2021.

LinkOut - more resources